carvedilol has been researched along with Endotoxin Shock in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasanthakumar, N | 1 |
1 other study available for carvedilol and Endotoxin Shock
| Article | Year |
|---|---|
Beta-Adrenergic Blockers as a Potential Treatment for COVID-19 Patients.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme 2; Betacoronavirus; Carvedilol; Coronavir | 2020 |